000			03842nam a22003735i 4500
001			391755
003			ES-MaUEC
005			20230102122608.0
007			cr nn 008mamaa
008			170403s2017 xxu| s |||| 0|eng d
020			_a9781493968695
024	7		_a10.1007/978-1-4939-6869-5 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
245	1	0	_aRecombinant Virus Vaccines _bMethods and Protocols _cedited by Maureen C. Ferran, Gary R. Skuse.
250			_a1st edition 2017
264		1	_aNew York, NY _bSpringer International Publishing _c2017
300			_a1 recurso en línea (X, 273 páginas) _b40 ilustraciones, 23 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aMethods in Molecular Biology _x1940-6029 _v1581
505	0		_aDevelopment of Novel Vaccines Against Infectious Diseases Based on Chimpanzee Adenoviral Vector -- Development of Recombinant Canarypox Viruses Expressing Immunogens -- Fowl Adenovirus-Based Vaccine Platform -- Development of Recombinant HSV-Based Vaccine Vectors -- Generating Recombinant Pseudorabies Virus for Use as a Vaccine Platform -- Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector -- Poxvirus Safety Analysis in the Pregnant Mouse Model, Vaccinia and Raccoonpox Viruses -- Development of Recombinant Arenavirus-Based Vaccines -- Development of Recombinant Measles Virus-Based Vaccines -- Recombinant Tri-Segmented Pichinde Virus as a Novel Live Viral Vaccine Platform -- Human Rhinovirus-A1 as an Expression Vector -- Generating Recombinant Vesicular Stomatitis Viruses for Use as Vaccine Platforms -- Alphavirus-Based Vaccines -- Display of HIV-1 Envelope Protein on Lambda Phage Scaffold as a Vaccine Platform -- Bacteriophage T4 as a Nanoparticle Platform to Display and Deliver Pathogen Antigens: Construction of an Effective Anthrax Vaccine.
520			_aThis volume provides readers with methods and protocols for understanding the development of recombinant viruses and their use as vaccines platforms. Recombinant Virus Vaccines: Methods and Protocols details the use of recombinant vaccines that are employed to either produce immunogens in vitro or elicit antibody production in vivo. The chapters in this book are divided into four parts: Part I explores double-stranded DNA viruses; Part II discusses negative sense single-stranded RNA viruses; Part III talks about positive sense single-stranded RNA viruses; and Part IV describes bacteriophages. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Thorough and cutting-edge, Recombinant Virus Vaccines: Methods and Protocols is a valuable resource for scientists and clinicians who are interested in learning about and adopting methods for use in basic and biomedical research directed toward generating and developing recombinant viral vaccines. .
700	1		_aFerran, Maureen C _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aSkuse, Gary R _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9781493968671
776	0	8	_iPrinted edition: _z9781493968688
776	0	8	_iPrinted edition: _z9781493983230
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-4939-6869-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
988			_aSpringer_Protocols_2017
999			_c391755 _d391755